Evidence map›Paper›PMID 40486032›Full record

ArticleMedical journal of the Islamic Republic of Iran2025

A Consensus Report on Management of Type 2 Diabetes Mellitus in Iran.

Alireza Esteghamati, Mojtaba Malek, Farhad Hosseinpanah Ghasabeh, Farzad Hadaegh, Mohammad Afkhami-Ardekani, Hamid Reza Aghai Meybodi, Mohammad Hossein Dabbaghmanesh, Fatemeh Ghaemi, Seyed Adel Jahed, Saeed Kalbasi and 7 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Medical journal of the Islamic Republic of Iran, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Alireza EsteghamatiEndocrinology and Metabolism Research Center (EMRC), Vali-Asr Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Mojtaba MalekResearch Center for Prevention of Cardiovascular Disease, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Tehran, Iran.
Farhad Hosseinpanah GhasabehObesity Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Farzad HadaeghPrevention of Metabolic Disorders Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Mohammad Afkhami-ArdekaniDiabetes Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Hamid Reza Aghai MeybodiEvidence-based Medicine Research Center, Endocrinology and Metabolism Clinical Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Mohammad Hossein DabbaghmaneshEndocrinology and Metabolism Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Fatemeh GhaemiDepartment of Transplantation & Disease Management, Vice Curative, Ministry of Health and Medical Education (MOHME), Tehran, Iran.
Seyed Adel JahedGabric Diabetes Education Association, Tehran, Iran.
Saeed KalbasiDepartment of Endocrinology and Metabolism, School of Medicine, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Mojtaba MehrdadDepartment of Endocrinology, Guilan University of Medical Sciences, Rasht, Iran.
Zohreh MousaviMetabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Mitra NiafarEndocrine Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Hassan RezvanianIsfahan Endocrine and Metabolism Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Mojgan SanjariEndocrinology and Metabolism Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, Iran.
Amir ZiaeeRasool Akram Medical Complex, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Mohammad E KhamsehEndocrine Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Tehran, Iran.ORCID https://orcid.org/0000-0003-4313-8440

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Type 2 diabetes mellitus (T2DM) is one of the most serious public health problems all over the world. Development of local consensus on management of T2DM, providing clinicians, researchers, and policymakers with updated and valid evidence in consideration of practical issues, is crucial. Therefore, we aimed to develop a consensus report on management of T2DM in Iran. Methods: A task force group comprised of experts in diabetes management reviewed published literature. The task force members reached the majority agreement on all recommendations after participating in several group meeting discussions. Results: The consensus provided recommendations on diverse aspects on management of people with T2DM in Iran. The recommendations covered the following topics: first-line treatment, diabetes management in people with obesity, combination therapy in people with T2DM, injectable therapy, and non-alcoholic fatty liver in people with T2DM. Conclusion: Considering evidence-based guidelines, the task force group developed a consensus to address important clinical issues in the management of people with T2DM in Iran.

Indexed as

ConsensusConsensus reportDiabetes ManagementIranType 2 Diabetes Mellitus (T2DM)

Identifiers

PMID40486032
PMCPMC12138759

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.